Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Lisata Therapeutics (LSTA) Non-Current Deffered Revenue (2016)

Lisata Therapeutics filings provide 4 years of Non-Current Deffered Revenue readings, the most recent being $4.6 million for Q4 2016.

For the quarter ending Q4 2016, Non-Current Deffered Revenue changed N/A year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Dec 2016, changed N/A, and an annual FY2016 reading of $4.6 million, changed N/A over the prior year.
Non-Current Deffered Revenue hit $4.6 million in Q4 2016 for Lisata Therapeutics, up from $143734.0 in the prior quarter.
The five-year high for Non-Current Deffered Revenue was $4.6 million in Q4 2016, with the low at $143734.0 in Q3 2012.